Listen to this article
Memic Innovative Surgery announced this week that three U.S. facilities acquired the Hominis robot-assisted surgical system. HCA Florida Healthcare’s Kendall Regional Medical Center, Advent Health Celebration and The Women’s Hospital at Jackson Memorial are the first U.S. facilities to acquire the Hominis surgical system.
Tel Aviv, Israel-based Memic’s Hominis system will now be used at the facilities in single-site, natural orifice laparoscopic-assisted transvaginal benign gynecological procedures, including benign hysterectomy. The company touts Hominis as the first and only FDA-authorized surgical robot with miniature humanoid-shaped arms with shoulder, elbow and wrist joints that provide human-level dexterity and 360-degree articulation.
Memic, which in August 2021 confirmed its plans to go public in a SPAC merger, designed the Hominis system to replicate the motions and capabilities of a surgeon’s arms, requiring a smaller footprint with lower costs than conventional robotic systems, the company said.
The system received FDA de novo clearance in February 2021. It raised $96 million in Series D funding in April 2021.
“We are proud to partner with these leading healthcare providers to empower surgeons with a better user experience and help them better serve the thousands of women who undergo gynecologic surgery each year,” Memic Co-Founder & CEO Dvir Cohen said in the release. “These sites establish a strong foundation for expanding market adoption of Hominis, including a leading robotic surgery center of excellence, a 450-bed hospital owned by one of the largest U.S. hospital systems, and a 1,550-bed nonprofit teaching hospital affiliated with an acclaimed medical school.
“With their support, we are expanding our commercial footprint to increase the reach of our proprietary technology and have a positive impact on the Florida region and elsewhere as we work to expand adoption of Hominis worldwide.”
Editor’s Note: This article first appeared on sister website MassDevice.